Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jean-Francois Ricci"'
Autor:
Edmond Chouinard, Patrick Neven, Jean-Francois Ricci, Tarek Sahmoud, Anna Komorowski, Gabriel N. Hortobagyi, Howard A. Burris, J. Thaddeus Beck, Shinzaburo Noguchi, Tetiana Taran, Martine Piccart, Kathleen I. Pritchard, Lee Bennett, Michael Gnant, Robyn R. Young, H. Bauly, Fabienne Lebrun, Hope S. Rugo, Katarína Petráková, José Baselga
Publikováno v:
Cancer. 119:1908-1915
BACKGROUND: The randomized, controlled BOLERO-2 (Breast Cancer Trials of Oral Everolimus) trial demonstrated significantly improved progression-free survival with the use of everolimus plus exemestane (EVE + EXE) versus placebo plus exemestane (PBO +
Publikováno v:
PharmacoEconomics. 26(11):951-967
Introduction: Gastrointestinal (GI) complications are common following renal transplantation. Discontinuing or reducing the dosage of mycophenolate mofetil can improve GI tolerability but adversely affect graft outcomes. This analysis was undertaken
Autor:
Jean-Francois Ricci, Fabrice Andre, Jie Zhang, R Degun, Guy Jerusalem, Giancarlo Benelli, Stephen Saletan, Patrick Neven, Nina Marinsek
Publikováno v:
BMC Cancer
Background Healthcare resource utilization in breast cancer varies by disease characteristics and treatment choices. However, lack of clarity in guidelines can result in varied interpretation and heterogeneous treatment management and costs. In Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f236637438fd83abdd7b9dab4bea4cc
http://www.biomedcentral.com/1471-2407/15/787
http://www.biomedcentral.com/1471-2407/15/787
Autor:
Donald L. Patrick, Donald M. Bushnell, Mona L. Martin, C. R. McBurney, Carmen Galani, Jean Francois Ricci, Margaret C. Reilly
Publikováno v:
Value in Health. 9(2):98-105
Objectives To assess the comparability, reliability, and subject acceptability of electronic data capture (EDC) versions of Irritable Bowel Syndrome—Quality of Life (IBS-QOL), EuroQoL (EQ-5D) and Work Productivity and Activity Impairment (WPAI:IBS)
Publikováno v:
Disease Management & Health Outcomes. 10(11):715-722
Objective: This study developed and validated a claims-based algorithm for identifying patients with irritable bowel syndrome (IBS) and investigated the characteristics of patients associated with a correct identification. Methods: Using a classifica
Autor:
Evgeny Degtyarev, Jonathan R. Strosberg, Simron Singh, Marianne Pavel, Matthew H. Kulke, Nicola Fazio, James C. Yao, Lida Bubuteishvili-Pacaud, Maureen P. Neary, Matthias Hunger, Jean-Francois Ricci, Jennifer Eriksson
Publikováno v:
Journal of Clinical Oncology. 35:285-285
285 Background: In the RADIANT-4 trial, everolimus (EVE) plus best supportive care (BSC) improved progression-free survival (PFS) compared to placebo (PBO) plus BSC in 302 patients with advanced progressive nonfunctional NET of gastrointestinal (GI)
Publikováno v:
Clinical Drug Investigation. 21:843-852
The beneficial effects of the serotonin 5-HT3 receptor antagonist alosetron on pain and discomfort in women with diarrhoea-predominant irritable bowel syndrome (IBS) may influence patients’ ability to perform normal daily activities such as work at
Publikováno v:
Journal of Managed Care Pharmacy. 2:415-419
OBJECTIVE: To define quality of life (QOL), health-related quality of life (HRQOL), highlight various principles, and applications useful for measuring QOL. DATA SOURCES: Recent clinical, sociologic, and health care literature. STUDY SELECTION: Not a
Autor:
Howard A, Burris, Fabienne, Lebrun, Hope S, Rugo, J Thaddeus, Beck, Martine, Piccart, Patrick, Neven, Jose, Baselga, Katarina, Petrakova, Gabriel N, Hortobagyi, Anna, Komorowski, Edmond, Chouinard, Robyn, Young, Michael, Gnant, Kathleen I, Pritchard, Lee, Bennett, Jean-Francois, Ricci, Hounayda, Bauly, Tetiana, Taran, Tarek, Sahmoud, Shinzaburo, Noguchi
Publikováno v:
Cancer. 119(10)
The randomized, controlled BOLERO-2 (Breast Cancer Trials of Oral Everolimus) trial demonstrated significantly improved progression-free survival with the use of everolimus plus exemestane (EVE + EXE) versus placebo plus exemestane (PBO + EXE) in pat
Autor:
Amanda Gilmore, Sandy Feng, Ning Kang, Jean-Francois Ricci, Kira L. Ryskina, J. Harold Helderman, Antonio P. Legorreta
Publikováno v:
Medical care. 45(6)
Objective In the United States, data on transplanted and waitlisted patients collected by the Organ Procurement and Transplantation Network (OPTN) have been widely used in transplantation research. Administrative claims data, collected by health plan